GPC3 and neoplasm: However, mutations or loss of expression have been reported in Simpson-Golabi-Behmel syndrome [21], ovarian carcinoma, breast cancer, and mesothelioma [22–25], suggesting that GPC3 functions as a tumour-suppressor gene.